Neurotropin (Argenes/Nippon Zoki)

神经妥乐平

Report date: 2022/01/14 13:23:58

Base Information

Drug NameNeurotropin (Argenes/Nippon Zoki)
Drug Alias NameNeurotropin
ClassificationBiologics
Mechanisms of ActionAdrenergic receptors alpha-2 agonists
TargetsAdrenergic receptors alpha-2
Therapy Area/IndicationsLow Back PainNeuralgia, PostherpeticReflex Sympathetic Dystrophy +[9] 
Global Approved IndicationsLow Back PainNeuralgia, PostherpeticPeriarthritis +[6] 
Approved Indications in ChinaLow Back PainPeriarthritisArthritis +[4] 
Original Approved Country/TerritoryJapan
Original Approved Date2008/03/14
Country/TerritoryUnited StatesMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNippon Zoki Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNippon Zoki Pharmaceutical Co LtdSun Yat-Sen University
Inactive CompaniesNational Institute Of Nursing Research
Active IndicationsLow Back PainNeuralgia, PostherpeticPeriarthritis +[7] 
Inactive IndicationsReflex Sympathetic DystrophyCausalgia

Other Information

ATC CodeN07XX
Related LinksN/A